C3 and hyperinsulinemic hypoglycemia, familial, 4: He S et al. [52] found that in a combined model of IRI and PHx, both C3 deficiency and high-dose CR2-Crry, an inhibitor of C3 activation, produced severe hepatic injury and high mortality, whereas low-dose CR2-Crry was protective and strengthened hepatic proliferative responses.